Search results
Onureg and dosage: Strengths, form, when to take, and more
Medical News Today· 2 days agoOnureg (azacitidine) is a brand-name drug prescribed to treat acute myeloid leukemia in certain...
Researchers discover that a type of childhood leukemia originates during fetal development
Medical Xpress· 6 days agoAcute myeloid leukemia is the second most common type of acute leukemia in childhood and can be...
Steps To-Marrow: Grandmother walks hundreds of miles to raise donor awareness
The Wenatchee World· 4 hours agoJeana Moore, 71, is not singing āIām Gonna Be,ā but she is walking hundreds of miles, thousands one...
Autolus reports promising results for obe-cel in leukemia study By Investing.com
Investing.com· 5 days agoAutolus Therapeutics plc (NASDAQ:AUTL), a biopharmaceutical company focused on T cell therapies for...
Novel CAR T therapy and shorter targeted therapy durations show promise for patients with leukemia
Medical Xpress· 5 days ago(ASCO) Annual Meeting. The novel anti-CD19 autologous chimeric antigen receptor (CAR) T cell therapy...
Autolus shares hold steady with Buy rating on Obe-cel market penetration By Investing.com
Investing.com· 6 days agoOn Thursday, Truist Securities maintained a Buy rating on shares of Autolus Therapeutics Plc...
Rgenta Therapeutics Presents Preclinical Data from Lead Program RGT-61159, a Potent Inhibitor of...
The Woonsocket Call· 5 days ago"The data presented at ASCO 2024 demonstrate efficient and specific modulation of the oncogenic transcription factor MYB, a target that historically has been difficult to drug, by RGT-61159 ...
Cancer Survivors Are Sharing The Weird Symptom That Made Them Go "Hm, Something Isn't Right Here,"...
BuzzFeed via Yahoo News· 4 days ago"If they tell you it might be cancer and have you come back in a couple of weeks for a biopsy, say...
Eldridge family establishes hospital fund to help other families of children with cancer
Quad-City Times· 6 days agoHudson McKearney is a 7-year-old boy who loves superheroes. Just before his second birthday,...
Gilead's (GILD) Urothelial Cancer Study Did Not Meet Its Primary Goal
Zacks via Yahoo Finance· 5 days agoGilead Sciences, Inc.'s (GILD) confirmatory TROPiCS-04 study on Trodelvy in locally advanced or...